NYSE · CIK 0001802255
GRDN Guardian Pharmacy Services, Inc.
Insider trading from SEC Form 4. Last filing 15 d ago. Close $41.28 on Oct 9, 2026, +76% from the 52-week low and -14% from the high.
Guardian Pharmacy Services, Inc. (GRDN) has 73 SEC Form 4 filings on file from 19 insiders, the latest filed on Sep 28, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
20 open-market trades have been scored at GRDN. The newest: John Ackerman (director) sold $33M of stock on Mar 20, 2026, filed Mar 24, 2026, scored 75 (notable). The largest of the 20 shown: William E Bindley (director and 10% owner) sold $106M on Mar 20, 2026, scored 65 (notable). 9 insiders sold within 14 days of each other around Mar 20, 2026.
GRDN closed at $41.28 on Oct 9, 2026, 76% above its 52-week low and 14% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Guardian Pharmacy Services, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | John Ackerman director sell | $33M 1,103,364 shares | -59% | +81% from low0% from high | |
| 65Notable | William E Bindley director, owner sell | $106M 3,570,677 shares | -44% | +81% from low0% from high | |
| 62Notable | Bindley Capital Partners I, LLC owner sell | $106M 3,570,677 shares | -44% | +81% from low0% from high | |
| 65Notable | Fred Burke See Remarks sell | $20M 671,432 shares | -44% | +81% from low0% from high | |
| 58Moderate | Cardinal Equity Fund, L.P. other sell | $8.2M 275,728 shares | -44% | +81% from low0% from high | |
| 65Notable | Kendall Forbes See Remarks sell | $10M 346,672 shares | -43% | +81% from low0% from high | |
| 65Notable | Thomas J Salentine Jr director, owner sell | $106M 3,570,677 shares | -44% | +81% from low0% from high | |
| 58Moderate | Pharmacy Investors, LLC other sell | $25M 827,636 shares | -44% | +81% from low0% from high | |
| 65Notable | David K Morris See Remarks sell | $5.6M 187,855 shares | -42% | +81% from low0% from high | |
| 28Weak | Steven D Cosler director buy | $100k 3,370 shares | +16% | +60% from low-7% from high | |
| 53Moderate | Cardinal Equity Fund, L.P. other sell | $6.5M 321,263 shares | -68% | +38% from low-17% from high | |
| 53Moderate | Pharmacy Investors, LLC other sell | $19M 964,316 shares | -68% | +38% from low-17% from high | |
| 75Notable | John Ackerman director sell | $26M 1,285,579 shares | -91% | +38% from low-17% from high | |
| 75Notable | William E Bindley director, owner sell | $84M 4,160,359 shares | -68% | +38% from low-17% from high | |
| 72Notable | Bindley Capital Partners I, LLC owner sell | $84M 4,160,359 shares | -68% | +38% from low-17% from high | |
| 75Notable | Fred Burke See Remarks sell | $18M 885,807 shares | -68% | +38% from low-17% from high | |
| 75Notable | Kendall Forbes See Remarks sell | $8.4M 415,049 shares | -67% | +38% from low-17% from high | |
| 75Notable | David K Morris See Remarks sell | $8.8M 437,759 shares | -67% | +38% from low-17% from high | |
| 75Notable | Thomas J Salentine Jr director, owner sell | $84M 4,160,359 shares | -68% | +38% from low-17% from high | |
| 36Weak | Steven D Cosler director buy | $149k 7,000 shares | +65% | - |
Transactions
The newest 50 of 135 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 27, 2026 | Fred Burke See Remarks | MOption exercise Class A Common Stock | +1,298,825 | - | - | 3,438,064 | 15 d ago |
| Sep 27, 2026 | Jeffrey Tuch See Remarks | MOption exercise Class A Common Stock | +55,578 | - | - | 231,847 | 15 d ago |
| Sep 27, 2026 | William E Bindley director, owner, other | MOption exercise Class A Common Stockindirect: By Bindley Capital Partners I, LLC | +6,100,175 | - | - | 16,669,666 | 15 d ago |
| Sep 27, 2026 | David K Morris See Remarks | MOption exercise Class A Common Stock | +641,870 | - | - | 896,341 | 15 d ago |
| Sep 27, 2026 | David Norman Martin See Remarks | MOption exercise Class A Common Stock | +39,865 | - | - | 140,905 | 15 d ago |
| Sep 27, 2026 | Cardinal Equity Fund, L.P. other | MOption exercise Class A Common Stock | +471,057 | - | - | 1,287,237 | 15 d ago |
| Sep 27, 2026 | Kendall Forbes See Remarks | MOption exercise Class A Common Stock | +608,570 | - | - | 1,651,059 | 15 d ago |
| Sep 27, 2026 | Bindley Capital Partners I, LLC owner, other | MOption exercise Class A Common Stock | +6,100,175 | - | - | 16,669,666 | 15 d ago |
| Sep 27, 2026 | Pharmacy Investors, LLC other | MOption exercise Class A Common Stock | +1,413,939 | - | - | 3,863,806 | 15 d ago |
| Sep 27, 2026 | Douglas Towns See Remarks | MOption exercise Class A Common Stock | +23,450 | - | - | 113,006 | 15 d ago |
| Sep 27, 2026 | Chris Crisafulli See Remarks | MOption exercise Class A Common Stock | +18,931 | - | - | 53,057 | 15 d ago |
| Sep 27, 2026 | Thomas J Salentine Jr director, owner, other | MOption exercise Class A Common Stockindirect: By Bindley Capital Partners I, LLC | +6,100,175 | - | - | 16,669,666 | 15 d ago |
| Sep 27, 2026 | William Franklin Mudd See Remarks | MOption exercise Class A Common Stock | +38,282 | - | - | 136,747 | 15 d ago |
| Sep 27, 2026 | John Ackerman director, other | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,939 | - | - | 3,863,806 | 15 d ago |
| Sep 27, 2026 | Richard Eakins Senior Vice President, Sales | MOption exercise Class A Common Stock | +36,052 | - | - | 134,930 | 15 d ago |
| Sep 27, 2026 | Robert Weir See Remarks | MOption exercise Class A Common Stock | +23,450 | - | - | 103,333 | 15 d ago |
| Sep 27, 2026 | Robert Weir See Remarks | MOption exercise Class B Common Stockderivative | -23,450 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Bindley Capital Partners I, LLC owner, other | MOption exercise Class B Common Stockderivative | -6,100,175 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | William Franklin Mudd See Remarks | MOption exercise Class B Common Stockderivative | -38,282 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Fred Burke See Remarks | MOption exercise Class B Common Stockderivative | -1,298,825 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Jeffrey Tuch See Remarks | MOption exercise Class B Common Stockderivative | -55,578 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Kendall Forbes See Remarks | MOption exercise Class B Common Stockderivative | -608,570 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Douglas Towns See Remarks | MOption exercise Class B Common Stockderivative | -23,450 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | William E Bindley director, owner, other | MOption exercise Class B Common Stockderivativeindirect: By Bindley Capital Partners I, LLC | -6,100,175 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | John Ackerman director, other | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 1,287,237 | 15 d ago |
| Sep 27, 2026 | David K Morris See Remarks | MOption exercise Class B Common Stockderivative | -641,870 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Cardinal Equity Fund, L.P. other | MOption exercise Class B Common Stockderivative | -471,057 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Pharmacy Investors, LLC other | MOption exercise Class B Common Stockderivative | -1,413,939 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Richard Eakins Senior Vice President, Sales | MOption exercise Class B Common Stockderivative | -36,052 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Chris Crisafulli See Remarks | MOption exercise Class B Common Stockderivative | -18,931 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | David Norman Martin See Remarks | MOption exercise Class B Common Stockderivative | -39,865 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | John Ackerman director, other | MOption exercise Class B Common Stockderivativeindirect: By Pharmacy Investors, LLC | -1,413,939 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | Thomas J Salentine Jr director, owner, other | MOption exercise Class B Common Stockderivativeindirect: By Bindley Capital Partners I, LLC | -6,100,175 | - | - | 0 | 15 d ago |
| Sep 27, 2026 | John Ackerman director, other | MOption exercise Class B Common Stockderivativeindirect: By Cardinal Equity Fund, L.P. | -471,057 | - | - | 0 | 15 d ago |
| May 5, 2026 | Steven D Cosler director | AGrant or award Class A Common Stock | +4,028 | $0.00 | $0 | 29,012 | May 7, 2026 |
| May 5, 2026 | Randall J Lewis director | AGrant or award Class A Common Stock | +4,028 | $0.00 | $0 | 15,071 | May 7, 2026 |
| May 5, 2026 | Mary Sue Patchett director | AGrant or award Class A Common Stock | +4,028 | $0.00 | $0 | 15,071 | May 7, 2026 |
| Mar 28, 2026 | John Ackerman director | MOption exercise Class A Common Stockindirect: By Pharmacy Investors, LLC | +1,413,939 | - | - | 2,449,867 | Mar 31, 2026 |
| Mar 28, 2026 | William E Bindley director, owner | MOption exercise Class A Common Stockindirect: By Bindley Capital Partners I, LLC | +6,100,175 | - | - | 10,569,491 | Mar 31, 2026 |
| Mar 28, 2026 | Pharmacy Investors, LLC other | MOption exercise Class A Common Stock | +1,413,939 | - | - | 2,449,867 | Mar 31, 2026 |
| Mar 28, 2026 | Bindley Capital Partners I, LLC owner | MOption exercise Class A Common Stock | +6,100,175 | - | - | 10,569,491 | Mar 31, 2026 |
| Mar 28, 2026 | Fred Burke See Remarks | MOption exercise Class A Common Stock | +1,298,826 | - | - | 2,139,239 | Mar 31, 2026 |
| Mar 28, 2026 | Thomas J Salentine Jr director, owner | MOption exercise Class A Common Stockindirect: By Bindley Capital Partners I, LLC | +6,100,175 | - | - | 10,569,491 | Mar 31, 2026 |
| Mar 28, 2026 | David K Morris See Remarks | MOption exercise Class A Common Stock | +641,869 | - | - | 896,341 | Mar 31, 2026 |
| Mar 28, 2026 | Cardinal Equity Fund, L.P. other | MOption exercise Class A Common Stock | +471,057 | - | - | 816,180 | Mar 31, 2026 |
| Mar 28, 2026 | Kendall Forbes See Remarks | MOption exercise Class A Common Stock | +608,570 | - | - | 1,061,826 | Mar 31, 2026 |
| Mar 28, 2026 | John Ackerman director | MOption exercise Class A Common Stockindirect: By Cardinal Equity Fund, L.P. | +471,057 | - | - | 816,180 | Mar 31, 2026 |
| Mar 28, 2026 | William E Bindley director, owner | MOption exercise Class B Common Stockderivativeindirect: By Bindley Capital Partners I, LLC | -6,100,175 | - | - | 6,100,175 | Mar 31, 2026 |
| Mar 28, 2026 | Bindley Capital Partners I, LLC owner | MOption exercise Class B Common Stockderivative | -6,100,175 | - | - | 6,100,175 | Mar 31, 2026 |
| Mar 28, 2026 | Fred Burke See Remarks | MOption exercise Class B Common Stockderivative | -1,298,826 | - | - | 1,298,825 | Mar 31, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- John Ackermandirector, other
- William E Bindleydirector, owner, other
- Bindley Capital Partners I, LLCowner, other
- Fred BurkeSee Remarks
- Steven D Coslerdirector
- Cardinal Equity Fund, L.P.other
- Chris CrisafulliSee Remarks
- Richard EakinsSenior Vice President, Sales
- Kendall ForbesSee Remarks
- Randall J Lewisdirector
- David Norman MartinSee Remarks
- David K MorrisSee Remarks
- William Franklin MuddSee Remarks
- Mary Sue Patchettdirector, coo, officer
- Pharmacy Investors, LLCother
- Thomas J Salentine Jrdirector, owner, other
- Douglas TownsSee Remarks
- Jeffrey TuchSee Remarks
- Robert WeirSee Remarks
Questions about GRDN
Answered from the filings on this page, as of the latest one.
Are insiders buying GRDN?
No. In the last 90 days no insider at Guardian Pharmacy Services, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade GRDN on the open market?
John Ackerman (director) sold $33M of GRDN on Mar 20, 2026 and filed the Form 4 on Mar 24, 2026. InsiderTell scored 75 (notable), with 9 insiders on the same side within 14 days.
How many insiders file Form 4 at Guardian Pharmacy Services, Inc.?
19 people have filed a Form 4 at Guardian Pharmacy Services, Inc., among them John Ackerman (director), William E Bindley (director and 10% owner), Bindley Capital Partners I, LLC (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.